With the advent of next-generation sequencing, we have an unprecedented ability to study
tumor and host genomes as well as those of the vast array of microorganisms that exist …

In the twenty first century, the changing epidemiology of inflammatory bowel disease (IBD)
globally with increasing disease incidence across many countries relates to the altered gut …

Despite advances in sequencing, lack of standardization makes comparisons across studies
challenging and hampers insights into the structure and function of microbial communities …

Manipulation of the gut microbiota via fecal microbiota transplantation (FMT) has shown
clinical promise in diseases such as recurrent Clostridioides difficile infection (rCDI) …

Fecal microbiota transplantation (FMT) is a method to directly change the recipient's gut
microbiota to normalize the composition and gain a therapeutic benefit. The history of FMT …

Triptolide (TP), a traditional Chinese medicine, has been reported to be effective in the
treatment of autoimmune diseases and exerting antineoplastic activity in several human …

Developments in high-throughput microbial genomic sequencing and other systems biology
techniques have given novel insight into the potential contribution of the gut microbiota to …

Faecal microbiota transplantation (FMT) is an important therapeutic option for Clostridium
difficile infection. Promising findings suggest that FMT may play a role also in the …

Background Clostridium difficile infection (CDI) is the commonest nosocomial cause of
diarrhoea. Faecal microbiota transplantation (FMT) is an approved treatment for recurrent or …

Gut microbiome has been increasingly recognized for its influence on a diverse array of
human diseases including cancer, and may also influence the outcome of cancer therapies …